600587 新华医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)8.33510.2919.70511.9695.470
总资产报酬率 ROA (%)3.9834.5814.0704.8042.022
投入资产回报率 ROIC (%)5.5056.4185.6346.5602.937

边际利润分析
销售毛利率 (%)26.31427.37326.43924.25123.277
营业利润率 (%)9.7867.5616.3127.5953.987
息税前利润/营业总收入 (%)9.9327.5216.6018.2445.104
净利润/营业总收入 (%)8.5406.7575.6775.8642.616

收益指标分析
经营活动净收益/利润总额(%)89.692104.644104.08876.226128.815
价值变动净收益/利润总额(%)7.27312.6801.10624.14314.804
营业外收支净额/利润总额(%)-0.326-2.488-1.691-0.300-5.653

偿债能力分析
流动比率 (X)1.3131.2581.0691.0260.961
速动比率 (X)0.8300.7850.6310.6430.575
资产负债率 (%)48.64950.48355.34954.63757.953
带息债务/全部投入资本 (%)31.72432.37639.79739.145--
股东权益/带息债务 (%)209.304202.896146.619147.483113.833
股东权益/负债合计 (%)99.99092.98875.14877.45265.482
利息保障倍数 (X)55.98952.27816.72812.2813.836

营运能力分析
应收账款周转天数 (天)67.77161.08463.54662.2570.000
存货周转天数 (天)172.705162.998140.631116.4830.000